Dova Pharmaceuticals Inc logo

DOVA - Dova Pharmaceuticals Inc News Story

$28.04 0.0  0.0%

Last Trade - 11/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £9.99m
Position in Universe th / 6841

BRIEF-Dova Pharmaceuticals Reports Second Quarter 2019 Operating And Financial Results

Tue 6th August, 2019 12:23pm
Aug 6 (Reuters) - Dova Pharmaceuticals Inc  DOVA.O :
    * DOVA PHARMACEUTICALS REPORTS SECOND QUARTER 2019 OPERATING
AND
FINANCIAL RESULTS
    * Q2 2019 NET SALES FROM DOPTELET OF $3.5 MILLION
    * QTRLY PRESCRIPTION REFERRALS INCREASED APPROXIMATELY 7%
COMPARED
TO Q1
    * SALES WERE NEGATIVELY AFFECTED BY COMPETITIVE PRICING
PRESSURE
AND PAYER RESTRICTIONS IN Q2 OF 2019

Source text for Eikon:  ID:nGNX5Gn19T 
Further company coverage:  DOVA.O 

 ((Reuters.Briefs@thomsonreuters.com;))
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.